-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
1H-Pyrazolo[3,4-b]pyridine,4-methoxy-(9CI) is a synthetic chemical compound that is widely used in the pharmaceutical industry as an intermediate for the synthesis of various drugs.
The production process of this compound involves several steps, which are carried out under controlled conditions to ensure the highest quality of the final product.
The first step in the production process of 1H-Pyrazolo[3,4-b]pyridine,4-methoxy-(9CI) is the synthesis of 1H-Pyrazolo[3,4-b]pyridine, which is a basic building block for the final product.
This compound is synthesized by reacting 2-pyrazinecarboxaldehyde with 3-amino-2-pyrazoline in the presence of a strong acid catalyst, such as sulfuric acid.
The reaction is carried out in a well-ventilated room, and the product is isolated by filtration and washed with water to remove any impurities.
The next step in the production process is the methylation of 1H-Pyrazolo[3,4-b]pyridine, which is carried out by treating the compound with methyl iodide in the presence of a weak acid catalyst, such as hydrochloric acid.
This step is critical for the formation of the desired 1H-Pyrazolo[3,4-b]pyridine,4-methoxy-(9CI) compound, as it introduces the methoxy group into the molecule.
The reaction is carefully monitored to ensure that the correct amount of methyl iodide is used, as excess methyl iodide can lead to unwanted side reactions.
After the methylation step, the product is extracted with a solvent, such as ethyl acetate, to remove any remaining impurities and to isolate the pure compound.
The extract is then dried with anhydrous sodium sulfate and filtered to remove any solid impurities.
The filtrate is then concentrated under reduced pressure to remove the solvent, and the resulting residue is dried under vacuum to remove any moisture.
The final step in the production process of 1H-Pyrazolo[3,4-b]pyridine,4-methoxy-(9CI) is the purification of the compound.
This is typically carried out by recrystallization, which involves dissolving the compound in a suitable solvent, such as ethanol, and allowing the crystals to form through slow evaporation.
The crystals are collected by filtration and washed with ethanol to remove any impurities, and then dried under vacuum to obtain the pure product.
In conclusion, the production process of 1H-Pyrazolo[3,4-b]pyridine,4-methoxy-(9CI) requires careful attention to detail and the use of specialized equipment and chemicals.
The steps involved in the process are carried out under controlled conditions to ensure the highest quality of the final product, which is used as an intermediate in the synthesis of various pharmaceuticals.
The purification step is critical for the removal of any impurities and for obtaining the desired product properties.
The successful production of 1H-Pyrazolo[3,4-b]pyridine,4-methoxy-(9CI) depends on the skills and expertise of the production team, as well as the proper selection and use of chemicals and equipment.